SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with Knife ($CAW) is trending as its dedicated community highlights its fully decentralized nature, multichain expansion across major ecosystems like Solana and Base, and a deflationary burn mechanism. The token's active 'cult' of holders is buzzing about ongoing development, significant partnerships, and its perceived utility, making it a prominent discussion point among meme coin enthusiasts.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending sharply on reports of an unexpected partnership with Novo Nordisk to sell GLP-1 weight-loss drugs, potentially ending a contentious lawsuit. The community is actively discussing the high short interest, anticipating a significant short squeeze fueled by this major catalyst.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata Inc. is trending as it approaches its Q4 earnings report, with community discussion centered on its strategic shift into Physical AI and Humanoid Robotics, coupled with aggressive recruitment and potential defense contracts. Investors are closely monitoring for growth acceleration, robust financial performance, and any emerging M&A speculation.

ProShares Trust - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

Escalating global geopolitical tensions and oil market uncertainty are driving intense community discussion around the ProShares Ultra VIX Short-Term Futures ETF, as traders fiercely debate the timing of potential volatility spikes against the instrument's inherent decay.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure (QURE) is trending due to news that a prominent FDA official, previously seen as a hurdle for gene therapies like AMT-130, is stepping down, which has ignited speculation among investors about a potentially more favorable regulatory path. This has led to a significant surge in the stock, as the community debates whether this change, following prior FDA rejection of uniQure's clinical data, will genuinely derisk its Huntington's disease treatment or if the enthusiasm is overblown.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is generating significant buzz as its crucial earnings report approaches, with investors debating its strong position in Agentic AI orchestration and robust balance sheet. A high short interest fuels anticipation for a potential short squeeze and a re-rating similar to Palantir.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. It also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment offers products and services sold for applications within the data center, communication networks, and commercial and industrial markets in North America and Latin America. The Asia Pacific segment includes products and services sold for applications within the data center, communication networks, and commercial or industrial markets throughout Greater China, Australia and New Zealand, Southeast Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Columbus, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv Holdings is trending due to its upcoming inclusion in the S&P 500 index, expected to drive significant passive fund buying. This elevation underscores its strong position as a key provider of cooling and power infrastructure for the rapidly expanding AI and data center markets, sparking community discussions about sustained growth despite some near-term profit-taking.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending as it secured significant financing at a favorable rate for its Polaris Forge 2 AI data center campus, positioning itself as a key player in the booming AI infrastructure sector. The community is actively discussing the imminent potential for major hyperscaler lease announcements, especially given recent power deals and a broader shift towards leasing specialized data center capacity.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community celebrates the imminent departure of a prominent FDA official, widely seen as a significant barrier to the approval of its Duchenne Muscular Dystrophy therapy, Deramiocel. This development, coupled with high anticipation for a late-breaking Phase 3 data presentation at a major medical conference next week, is fueling intense bullish sentiment and expectations for a rapid regulatory decision.

Blackstone, Inc. engages in the provision of investment and fund management services. It operates through the following segments: Real Estate, Private Equity, Credit and Insurance, and Hedge Fund Solutions. The Real Estate segment includes management of opportunistic real estate funds, Core+ real estate funds, high-yield real estate debt funds, and liquid real estate debt funds. The Private Equity segment consists of management of flagship corporate private equity funds, sector and geographically focused corporate private equity funds, core private equity funds, an opportunistic investment platform, a secondary fund of funds business, infrastructure-focused funds, a life sciences investment platform, a growth equity investment platform, a multi-asset investment program for eligible high net worth investors and a capital markets services business. The Credit and Insurance segment refers to Blackstone Credit, which is organized into two overarching strategies: private credit which includes mezzanine direct lending funds, private placement strategies, stressed and distressed strategies and energy strategies, and liquid credit which consists of CLOs, closed-ended funds, open ended funds and separately managed accounts. In addition, the segment includes an insurer-focused platform, an asset-based finance platform, and publicly traded master limited partnership investment platform. The Hedge Fund Solutions segment focuses on Blackstone Alternative Asset Management, which manages a broad range of commingled and customized hedge fund of fund solutions. It also includes a GP Stakes business and investment platforms that invest directly, as well as investment platforms that seed new hedge fund businesses and create alternative solutions through daily liquidity products. The company was founded by Stephen Allen Schwarzman in 1985 and is headquartered in New York, NY.

Blackstone Inc

Blackstone is under pressure following significant redemption requests from its BCRED private credit fund, fueling broader market concerns about liquidity and credit quality in the alternative asset sector, as the community weighs management's defense against potential private credit risks and the firm's long-term AI infrastructure growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amarin (NASDAQ:AMRN) Stock Rating Upgraded by Zacks Research

Zacks Research raised Amarin from a "strong sell" rating to a "hold" rating in a report on Wednesday...

AMRN Stock Soars 37.7% in a Year: Here's What You Need to Know 

Amarin shares surge 37.7% in a year as restructuring, cost cuts and expanding Vazkepa partnerships for international growth fuel optimism.

Amarin (NASDAQ:AMRN) Stock Rating Lowered by Wall Street Zen

Wall Street Zen cut shares of Amarin from a "buy" rating to a "hold" rating in a research note on Saturday...

Amarin's Q4 Earnings Beat Estimates, Stock Down as Revenues Miss 

AMRN swings to Q4 profit and beats estimates, but revenues decline 21% as Vascepa sales slide and shares fall 9% on the mixed results.

Amarin (NASDAQ:AMRN) Announces Earnings Results

Amarin (NASDAQ:AMRN - Get Free Report) announced its earnings results on Wednesday. The biopharmaceutical company reported $0.01 earnings per share (EPS) for the quarter, topping analysts' consensus...

Amarin Q4 Earnings Call Highlights

Amarin (NASDAQ:AMRN) executives told investors that 2025 marked a substantial achievement year as the company advanced a strategic pivot toward a more partnered international commercial model and...

Amarin Corp Earnings Report: Q4 Overview

Amarin (AMRN) to Release Quarterly Earnings on Wednesday

Amarin (NASDAQ:AMRN) will be releasing its Q4 2025 earnings before the market opens on Wednesday, February 25. (View Earnings Report at...

Amarin (NASDAQ:AMRN) Stock Rating Lowered by Zacks Research

Zacks Research downgraded shares of Amarin from a "hold" rating to a "strong sell" rating in a research note on Tuesday...

New Strong Sell Stocks for January 28th

AMRN, AMTB and AAWH have been added to the Zacks Rank #5 (Strong Sell) List on January 28th, 2026.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

AMRN
Amarin Corp - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AMRN News

AMRNAmarin Corp - ADR